C 008: THE RATIONALE OF ANALGESIS COMBINATIONS

Excerpt:


J Pharm Pharmacogn Res 2(Suppl. 1): S27, 2014 Special supplement with the abstract book of LATINFARMA 2013 Conference C 008: THE RATIONALE OF ANALGESIS COMBINATIONS Granizo E. Universidad Central de Ecuador. Abstract No single analgesic agent is perfect and no single analgesic can treat all types of pain. Oral fixed drug combinations analgesics potentially have … Continue reading C 008: THE RATIONALE OF ANALGESIS COMBINATIONS

J Pharm Pharmacogn Res 2(Suppl. 1): S27, 2014

Special supplement with the abstract book of LATINFARMA 2013

Conference

C 008: THE RATIONALE OF ANALGESIS COMBINATIONS

Granizo E.

Universidad Central de Ecuador.
Abstract

No single analgesic agent is perfect and no single analgesic can treat all types of pain. Oral fixed drug combinations analgesics potentially have a number of advantages over monotherapy, but these benefits can only be attained through careful design that is not the case in some available preparations.

A combination is most effective when the individual agents act through different analgesic mechanisms and act synergistically. The fixed-dose combinations analgesics are of value only when they have bee developed according to rationale pharmacokinetic and pharmacodynamic criteria.

This overview highlights the therapeutic potential of combining analgesic medications with different mechanisms of action like a NSAIDs drugs or acetaminophen with an opioid or tramadol.

Toxicity evaluation of Ruta angustifolia leaves ethanolic extract
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 437-447, May-June 2023. DOI: https://doi.org/10.56499/jppres23.1609_11.3.437 Original Article Acute and repeated dose 28-day oral toxicity of Ruta angustifolia Pers. leaves ethanolic extract in Wistar rats [Toxicidad oral aguda y por dosis repetidas durante 28 días del extracto etanólico de hojas de Ruta angustifolia Pers. en ratas Wistar] Tutik … Continue reading Toxicity evaluation of Ruta angustifolia leaves ethanolic extract
Adolescents in Indonesia and COVID-19 pandemic
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 426-436, May-June 2023. DOI: https://doi.org/10.56499/jppres22.1560_11.3.426 Original Article Perception, mental health, and social media exposure on adolescents in Indonesia during COVID-19 pandemic [Percepción, salud mental y exposición a los medios sociales en adolescentes de Indonesia durante la pandemia de COVID-19] Efa Nugroho1*, Alfiana Ainun Nisa1, Widya Hary Cahyati1, … Continue reading Adolescents in Indonesia and COVID-19 pandemic
Decaffeinated green tea and coffee extracts and metabolic syndrome
J. Pharm. Pharmacogn. Res., vol. 11, no. 3, pp. 414-425, May-June 2023. DOI: https://doi.org/10.56499/jppres23.1593_11.3.414 Original Article Decaffeinated green tea and green coffee extracts as metformin’s add-on enhance metabolic syndrome risk factors and improve the cardiac insulin-gene-related pathway [Extractos de té verde y café verde descafeinados como complemento de la metformina mejoran los factores de riesgo del … Continue reading Decaffeinated green tea and coffee extracts and metabolic syndrome

© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health

Made with ♥ by AVAGAX Studio